Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Trace And Track: DTAB approves proposal to track 300 pharmaceutical brands

      Trace And Track: DTAB approves proposal to track 300 pharmaceutical brands

      Ruby Khatun Khatun26 May 2018 10:45 AM IST
      New Delhi: In order to curb the nuisance of spurious drugs in the domestic market the Drugs Technical Advisory Board (DTAB) has granted the approval...
      Zydus Cadila gets USFDA nod for prostate drug

      Zydus Cadila gets USFDA nod for prostate drug

      Ruby Khatun Khatun26 May 2018 10:45 AM IST
      New Delhi: Zydus Cadila has received final approval from the US health regulator to market Dutasteride and Tamsulosin Hydrochloride capsules.The drug...
      Sun Pharma Q4 net up 7 percent at Rs 1,309 crore

      Sun Pharma Q4 net up 7 percent at Rs 1,309 crore

      Ruby Khatun Khatun26 May 2018 10:30 AM IST
      New Delhi: Drug major Sun Pharma posted 6.96 percent increase in its consolidated net profit at Rs 1,308.96 crore for the fourth quarter ended March...
      Pfizer to pay 23.85 million dollar to settle US co-payment kickback probe

      Pfizer to pay 23.85 million dollar to settle US co-payment kickback probe

      Ruby Khatun Khatun26 May 2018 10:15 AM IST
      Pfizer Inc agreed to pay $23.85 million to resolve U.S. charges that it used a purportedly independent charity to pay illegal kickbacks to Medicare...
      IHH Healthcare extends validity of revised offer for Fortis to June 30

      IHH Healthcare extends validity of revised offer for Fortis to June 30

      Ruby Khatun Khatun26 May 2018 10:00 AM IST
      New Delhi: Malaysian firm IHH Healthcare Berhard on Friday extended the acceptance period for its enhanced revised proposal for acquiring Fortis to...
      FDA approves BioMarin rare metabolic disorder drug

      FDA approves BioMarin rare metabolic disorder drug

      Ruby Khatun Khatun26 May 2018 9:45 AM IST
      U.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the...
      Novartis receives EU approval for biosimilar Zessly

      Novartis receives EU approval for biosimilar Zessly

      Ruby Khatun Khatun26 May 2018 9:30 AM IST
      ZURICH: Novartis said its Sandoz division received approval from the European Commission for its biosimilar Zessly (infliximab) in...
      Manipal-TPG combine extends validity of revised offer for Fortis

      Manipal-TPG combine extends validity of revised offer for Fortis

      Ruby Khatun Khatun25 May 2018 10:40 AM IST
      New Delhi: Manipal-TPG combine has said it has extended the validity of its modified offer for Fortis Healthcare to June 6, 2018.On May 17, Malaysian...
      Johnson and Johnson must pay 4 million dollar in punitive damages in latest asbestos cancer trial

      Johnson and Johnson must pay 4 million dollar in punitive damages in latest asbestos cancer trial

      Ruby Khatun Khatun25 May 2018 10:22 AM IST
      A California jury ordered Johnson and Johnson to pay $4 million in punitive damages to a woman who said she developed cancer after being exposed to...
      India, Netherlands, Sweden collaborate for HIV/AIDS research

      India, Netherlands, Sweden collaborate for HIV/AIDS research

      Ruby Khatun Khatun25 May 2018 10:17 AM IST
      New Delhi: The government has collaborated with Netherlands and Sweden for a research programme on HIV/AIDS, said Bruno Bruins, Minister of Medical...
      CureFit Healthcare acquires Fitness First

      CureFit Healthcare acquires Fitness First

      Ruby Khatun Khatun25 May 2018 10:06 AM IST
      New Delhi: Health-technology startup CureFit said it has inked deal with Oaktree Capital Management under which Fitness First, chain of fitness...
      Medical device maker Medtronic reports 25.5 percent rise in profit

      Medical device maker Medtronic reports 25.5 percent rise in profit

      Ruby Khatun Khatun25 May 2018 9:45 AM IST
      Medtronic Plc reported a 25.5 percent rise in quarterly profit on Thursday on higher demand for its heart devices.Net income attributable to the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok